N/A
N=40
New Patient Support Program in Type 2 Diabetes
Diabetes Mellitus, Type 2
Bottom Line
View on ClinicalTrials.gov: NCT03752567 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcome: Primary: Percent of Participants With Adherence to the PDTA — 98; 98; 98 percentage of participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Follow up (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Farmacia La Regina s.r.l.
- Primary completion
- Oct 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent of Participants With Adherence to the PDTA |
98; 98; 98 | — |
| SECONDARY Waiting Time |
117; 120 | — |
| SECONDARY Levels of Arterial Pressure |
-13; -9 | — |
| SECONDARY Levels of HbA1c |
-4 | — |
| SECONDARY Levels of LDL-cholesterol |
-10 | — |
| SECONDARY Economic Impact |
210.25 | — |
Summary
Non-profit observational study on the role of the community pharmacist and the "pharmacy of services" in the case management of the diabetic patient
Eligibility Criteria
Criteria Inclusion:
- age> 18 years,
- patients with type 2 diabetes mellitus diagnosis;
- able to express consent to the study.
Exclusion Criteria
- Nobody
Data sourced from ClinicalTrials.gov (NCT03752567). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.